Fairbanks Today

Trust is a currency, and Canada has decided America can no longer be relied upon to spend it wisely. Since Donald Trump launched his second-term trade war—complete with tariffs, annexation threats, and quiet meetings with separatist groups—Canadian officials, business leaders, and everyday consumers have been working to loosen a economic bond that once seemed unbreakable. Prime Minister Mark Carney set an ambitious goal: double non-US exports within a decade. He's already halfway there, with non-US exports up more than 40% in a single year, fueled by soaring gold and energy sales to Britain, China, and the EU. But the numbers tell a more complicated story than simple triumph. America remains Canada's dominant trading partner by a factor of eight over its nearest competitor, and the physical and economic ties binding the two countries run deep—deeper than politics alone can sever. Business investment has stalled even as infrastructure spending hits record highs. Factories are retooling, supply chains are fracturing, and nearly half of Canadians believe the worst economic pain is still ahead. This is the story of a country forced to reconsider its oldest, closest economic relationship—not by choice, but by necessity. It's a story of boycotts and burner phones, of pipelines rushed through approval and tourism dollars redirected overseas, of a nation discovering just how painful, and how possible, independence from a superpower neighbor can be.

In 1999, a minor car accident left Professor Clark Elliott with a concussion so severe it unraveled his mind in ways no scan could detect. He could teach a graduate seminar but not walk down stairs. He could write but not read. Once, hungry for a snack, he stood paralyzed between a piece of salami and an apple for two days, unable to initiate the simple act of choosing. For a decade, doctors found nothing wrong and sent him home. Then, through a mix of geometric puzzle exercises and a bizarre vision test involving ringing bells and prism lenses placed over closed eyelids, he recovered almost entirely. This story digs into Elliott's memoir to ask an uncomfortable question: did these unconventional treatments actually work, or did a desperate man simply get better on his own timeline? The evidence is thin and strange—one key study was authored by Elliott himself and never fully published. But the deeper investigation reveals something larger about post-concussion syndrome itself: it may resist the medical gold standard of randomized trials precisely because it damages each brain differently. That mismatch between how medicine proves things and how individual patients actually heal has left hundreds of thousands of concussion sufferers each year navigating forums, testimonials, and expensive guesswork—caught between rigorous science that doesn't apply to them and miracle stories that might not be real.